AviadoBio
aviadobio.comLocations
United Kingdom · London, UK
industry
Biotechnology · DeepTech · Education · Health
Size
51-200 employees
Stage
Series A
founded in
2019
AviadoBio mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.
Something looks off?Open jobs at AviadoBio